Our Reports
Automotive Reports Electronics & Semiconductor Telecom & IT Technology & IT Consumer Goods Healthcare Food & Beverages Chemical
Our Links
About Us Contact Us Press Release News Our Blogs

Int'l : +1(646) 600-5072 | query@kbvresearch.com


The Global Laser BPH Devices Market is Predict to reach $619.9 Billion by 2028, at a CAGR of 5.3%

Special Offering :

Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support

Laser BPH Devices Market Growth, Trends and Report Highlights

According to a new report, published by KBV research, The Global Laser BPH Devices Market size is expected to reach $619.9 Million by 2028, rising at a market growth of 5.3% CAGR during the forecast period.

The Clinics segment is showcasing a CAGR of 5.7% during (2022 - 2028). This is due to the increasing preference for patients to visit specialized centers for a particular illness. Clinics are known to provide specialized care to their patients due to their small size. Also, clinics are usually the primary choice of care for many people. The specialized care offered by the clinics, combined with other factors, drives the segment’s expansion in the projected period.

The Photoselective Vaporization of Prostate segment acquired maximum revenue share in the Global Laser BPH Devices Market by Procedure in 2021 thereby, achieving a market value of $524.4 Million by 2028. The growth is due to the short hospital stays, generally outpatient procedures. This process is utilized to treat prostates that are mild to moderately large. Also, this treatment causes minimal bleeding to the patient, and the patient usually has a fast recovery compared to other surgical options. The rapid recovery and minimal bleeding are anticipated to boost the segment expansion in the projected period.

The Green Light Laser segment has shown the growth rate of 5.5% during (2022 - 2028). The growth is attributed to the instant relief from urinary symptoms provided to the patient. After the procedure, the urine flow is known to get instantly restored. This procedure is done under anesthesia by placing a telescope into the urethra up to the prostate level. Also, green light prostatectomy is known to combine the effectiveness of a TURP surgical procedure with limited side effects. Hence, the instant relief provided to the patient with fewer side effects is expected to drive the segment’s growth.

The North America market dominated the Global Laser BPH Devices Market by Region in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $230.6 Million by 2028. The Asia Pacific market is experiencing a CAGR of 6.3% during (2022 - 2028). Additionally, The Europe market would showcase a CAGR of 4.7% during (2022 - 2028).

Full Report: https://www.kbvresearch.com/laser-bph-devices-market/

The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Boston Scientific Corporation, OmniGuide, Inc., Richard Wolf GmbH, Coloplast Group, Agiliti, Inc., HealthTronics, Inc. (Altaris Capital Partners, LLC), Endo International PLC, Teleflex, Inc., Biolitec AG, and Metrum Cryoflex Sp. z o.o.

Global Laser BPH Devices Market Segmentation

By End User

  • Hospitals
  • Clinics
  • Others

By Procedure

  • Photoselective Vaporization of Prostate
  • Holium Laser Ablation

By Type

  • Holmium Laser
  • Thulium Laser
  • Green Light Laser
  • Others

By Geography

  • North America
    • US
    • Canada
    • Mexico
    • Rest of North America
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Singapore
    • Malaysia
    • Rest of Asia Pacific
  • LAMEA
    • Brazil
    • Argentina
    • UAE
    • Saudi Arabia
    • South Africa
    • Nigeria
    • Rest of LAMEA

Companies Profiled

  • Boston Scientific Corporation
  • OmniGuide, Inc.
  • Richard Wolf GmbH
  • Coloplast Group
  • Agiliti, Inc.
  • HealthTronics, Inc. (Altaris Capital Partners, LLC)
  • Endo International PLC
  • Teleflex, Inc.
  • Biolitec AG
  • Metrum Cryoflex Sp. z o.o.

Related Reports:



SUBSCRIPTION MODEL